[1] |
World Health Organization. Global tuberculosis report 2022. Geneva: World Health Organization, 2022.
|
[2] |
罗红, 郑碧英, 徐军发. 巨噬细胞凋亡抗结核分枝杆菌感染的研究进展. 细胞与分子免疫学杂志, 2019, 35(7): 665-670. doi:10.13423/j.cnki.cjcmi.008849.
|
[3] |
Murray PJ. Macrophage Polarization. Annu Rev Physiol, 2017, 79: 541-566. doi:10.1146/annurev-physiol-022516-034339.
pmid: 27813830
|
[4] |
Orecchioni M, Ghosheh Y, Pramod AB, et al. Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS-) vs. Alternatively Activated Macrophages. Front Immunol, 2019, 10: 1-14. doi:10.3389/fimmu.2019.01084.
|
[5] |
唐俭, 陈旭昕, 韩志海. 巨噬细胞极化及极化调控的研究进展. 转化医学杂志, 2019, 8(6): 373-376.
|
[6] |
Kong X, Gao J. Macrophage polarization: a key event in the secondary phase of acute spinal cord injury. J Cell Mol Med, 2016, 21(5): 941-954. doi:10.1111/jcmm.13034.
|
[7] |
Recalcati S, Gammella E, Cairo G. Ironing out Macrophage Immunometabolism. Pharmaceuticals (Basel), 2019, 12(2): 94. doi:10.3390/ph12020094.
|
[8] |
Marrocco A, Ortiz LA. Role of metabolic reprogramming in pro-inflammatory cytokine secretion from LPS or silica-activated macrophages. Front Immunol, 2022, 13:936167. doi:10.3389/fimmu.2022.936167.
|
[9] |
Ahmad F, Rani A, Alam A, et al. Macrophage: A Cell With Many Faces and Functions in Tuberculosis. Front Immunol, 2022, 13: 747799. doi:10.3389/fimmu.2022.747799.
|
[10] |
Zhang YH, He M, Wang Y, et al. Modulators of the Balance between M1 and M2 Macrophages during Pregnancy. Front Immunol, 2017, 8: 120. doi:10.3389/fimmu.2017.00120.
|
[11] |
Zhai W, Wu F, Zhang Y, et al. The Immune Escape Mechanisms of Mycobacterium Tuberculosis. Int J Mol Sci, 2019, 20(2): 340. doi:10.3390/ijms20020340.
|
[12] |
Shapouri-Moghaddam A, Mohammadian S, Vazini H, et al. Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol, 2018, 233(9): 6425-6440. doi:10.1002/jcp.26429.
pmid: 29319160
|
[13] |
Röszer T. Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms. Mediators Inflamm, 2015, 2015: 816460. doi:10.1155/2015/816460.
|
[14] |
Muñoz J, Akhavan NS, Mullins AP, et al. Macrophage Polari-zation and Osteoporosis: A Review. Nutrients, 2020, 12(10): 2999. doi:10.3390/nu12102999.
|
[15] |
Silva Miranda M, Breiman A, Allain S, et al. The tuberculous granuloma: an unsuccessful host defence mechanism providing a safety shelter for the bacteria? Clin Dev Immunol, 2012, 2012: 139127. doi:10.1155/2012/139127.
|
[16] |
Cohen SB, Gern BH, Delahaye JL, et al. Alveolar Macrophages Provide an Early Mycobacterium tuberculosis Niche and Initiate Dissemination. Cell Host Microbe, 2018, 24(3): 439-446. e4. doi:10.1016/j.chom.2018.08.001.
pmid: 30146391
|
[17] |
Cohen SB, Gern BH, Urdahl KB. The Tuberculous Granuloma and Preexisting Immunity. Annu Rev Immunol, 2022, 40: 589-614. doi:10.1146/annurev-immunol-093019-125148.
pmid: 35130029
|
[18] |
于佳佳, 唐神结. 巨噬细胞极化在结核病中的作用研究进展. 中华临床感染病杂志, 2019, 12(3): 229-235. doi:10.3760/cma.j.issn.1674-2397.2019.03.014.
|
[19] |
Huang Z, Luo Q, Guo Y, et al. Mycobacterium tuberculosis-Induced Polarization of Human Macrophage Orchestrates the Formation and Development of Tuberculous Granulomas In Vitro. PLoS One, 2015, 10(6): e0129744. doi:10.1371/journal.pone.0129744.
|
[20] |
Borchers A, Pieler T. Programming pluripotent precursor cells derived from Xenopus embryos to generate specific tissues and organs. Genes (Basel), 2010, 1(3): 413-426. doi:10.3390/genes1030413.
|
[21] |
Cho HJ, Lim YJ, Kim J, et al. Different macrophage polarization between drug-susceptible and multidrug-resistant pulmonary tuberculosis. BMC Infect Dis, 2020, 20(1): 81. doi:10.1186/s12879-020-4802-9.
pmid: 31996142
|
[22] |
Kinsella RL, Zhu DX, Harrison GA, et al. Perspectives and Advances in the Understanding of Tuberculosis. Annu Rev Pathol, 2021, 16: 377-408. doi:10.1146/annurev-pathol-042120-032916.
pmid: 33497258
|
[23] |
Prados-Rosales R, Baena A, Martinez LR, et al. Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice. J Clin Invest, 2011, 121(4): 1471-1483. doi:10.1172/JCI44261.
pmid: 21364279
|
[24] |
Liu CH, Liu H, Ge B. Innate immunity in tuberculosis: host defense vs pathogen evasion. Cell Mol Immunol, 2017, 14(12): 963-975. doi:10.1038/cmi.2017.88.
|
[25] |
Naqvi KF, Endsley JJ. Myeloid C-Type Lectin Receptors in Tuberculosis and HIV Immunity: Insights Into Co-infection? Front Cell Infect Microbiol, 2020, 10: 263. doi:10.3389/fcimb.2020.00263.
|
[26] |
Lugo-Villarino G, Troegeler A, Balboa L, et al. The C-Type Lectin Receptor DC-SIGN Has an Anti-Inflammatory Role in Human M(IL-4) Macrophages in Response to Mycobacterium tuberculosis. Front Immunol, 2018, 9: 1123. doi:10.3389/fimmu.2018.01123.
pmid: 29946317
|
[27] |
Huang Z, Gao C, Chi X, et al. IL-37 Expression is Upregulated in Patients with Tuberculosis and Induces Macrophages Towards an M2-like Phenotype. Scand J Immunol, 2015, 82(4): 370-379. doi:10.1111/sji.12326.
pmid: 26073153
|
[28] |
Guler R, Parihar SP, Savvi S, et al. IL-4Ralpha-dependent alternative activation of macrophages is not decisive for Mycobacterium tuberculosis pathology and bacterial burden in mice. PLoS One, 2015, 10(3): e0121070. doi:10.1371/journal.pone.0121070.
|
[29] |
García-González G, Sánchez-González A, Hernández-Bello R, et al. Triggering of protease-activated receptors (PARs) induces alternative M2 macrophage polarization with impaired plasticity. Mol Immunol, 2019, 114: 278-288. doi:10.1016/j.molimm.2019.08.004.
pmid: 31419704
|
[30] |
Chen D, Li G, Fu X, et al. Wnt5a Deficiency Regulates Inflammatory Cytokine Secretion, Polarization, and Apoptosis in Mycobacterium tuberculosis-Infected Macrophages. DNA Cell Biol, 2017, 36(1): 58-66. doi:10.1089/dna.2016.3418.
|
[31] |
Refai A, Gritli S, Barbouche MR, et al. Mycobacterium tuberculosis Virulent Factor ESAT-6 Drives Macrophage Differentiation Toward the Pro-inflammatory M1 Phenotype and Subsequently Switches It to the Anti-inflammatory M2 Phenotype. Front Cell Infect Microbiol, 2018, 8: 327. doi:10.3389/fcimb.2018.00327.
|
[32] |
Khan A, Zhang K, Singh VK, et al. Human M1 macrophages express unique innate immune response genes after mycobacterial infection to defend against tuberculosis. Commun Biol, 2022, 5(1): 480. doi:10.1038/s42003-022-03387-9.
pmid: 35590096
|
[33] |
Singh VK, Chau E, Mishra A, et al. CD44 receptor targeted nanoparticles augment immunity against tuberculosis in mice. J Control Release, 2022, 349: 796-811. doi:10.1016/j.jconrel.2022.07.040.
|
[34] |
Shobaki N, Sato Y, Suzuki Y, et al. Manipulating the function of tumor-associated macrophages by siRNA-loaded lipid nanoparticles for cancer immunotherapy. J Control Release, 2020, 325: 235-248. doi:10.1016/j.jconrel.2020.07.001.
|
[35] |
Wang C, Zhang Y, Dong Y. Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications. Acc Chem Res, 2021, 54(23): 4283-4293. doi:10.1021/acs.accounts.1c00550.
|
[36] |
Liang T, Chen J, Xu G, et al. STAT1 and CXCL 10 involve in M1 macrophage polarization that may affect osteolysis and bone remodeling in extrapulmonary tuberculosis. Gene, 2022, 809: 146040. doi:10.1016/j.gene.2021.146040.
|
[37] |
Arish M, Naz F. Sphingosine-1-phosphate receptors 2 and 3 reprogram resting human macrophages into M1 phenotype following mycobacteria infection. Curr Res Immunol, 2022, 3: 110-117. doi:10.1016/j.crimmu.2022.05.004.
|
[38] |
Wan M, Tang X, Rekha RS, et al. Prostaglandin E2 suppresses hCAP18/LL-37 expression in human macrophages via EP2/EP4: implications for treatment of Mycobacterium tuberculosis infection. FASEB J, 2018, 32(5): 2827-2840. doi:10.1096/fj.201701308.
|
[39] |
Ge G, Jiang H, Xiong J, et al. Progress of the Art of Macrophage Polarization and Different Subtypes in Mycobacterial Infection. Front Immunol, 2021, 12: 752657. doi:10.3389/fimmu.2021.752657.
|
[40] |
Gail DP, Suzart VG, Du W, et al. Mycobacterium tuberculosis impairs human memory CD4+ T cell recognition of M2 but not M1-like macrophages. iScience, 2023, 26(9): 107706. doi:10.1016/j.isci.2023.107706.
|
[41] |
Bedard M, van der Niet S, Bernard EM, et al. A terpene nucleoside from M.tuberculosis induces lysosomal lipid storage in foamy macrophages. J Clin Invest, 2023, 133(6):e161944. doi:10.1172/JCI161944.
|
[42] |
Gong Z, Han S, Liang T, et al. Mycobacterium tuberculosis effector PPE 36 attenuates host cytokine storm damage via inhibiting macrophage M1 polarization. J Cell Physiol, 2021, 236(11): 7405-7420. doi:10.1002/jcp.30411.
|
[43] |
Sha S, Shi Y, Tang Y, et al. Mycobacterium tuberculosis Rv1987 protein induces M2 polarization of macrophages through activating the PI3K/Akt1/mTOR signaling pathway. Immunol Cell Biol, 2021, 99(6): 570-585. doi:10.1111/imcb.12436.
|
[44] |
Zhang Y, Li S, Liu Q, et al. Mycobacterium tuberculosis Heat-Shock Protein 16.3 Induces Macrophage M2 Polarization Through CCRL2/CX3CR1. Inflammation, 2020, 43(2): 487-506. doi:10.1007/s10753-019-01132-9.
|
[45] |
师长宏, 江鹰, 赵勇, 等. 结核分枝杆菌Hsp16.3蛋白影响小鼠巨噬细胞自噬形成的实验研究. 细胞与分子免疫学杂志, 2011, 27(12): 1301-1303. doi:10.13423/j.cnki.cjcmi.006235.
|
[46] |
Lopes RL, Borges TJ, Araújo JF, et al. Extracellular mycobacterial DnaK polarizes macrophages to the M2-like phenotype. PLoS One, 2014, 9(11): e113441. doi:10.1371/journal.pone.0113441.
|
[47] |
BoseDasgupta S, Pieters J. Macrophage-microbe interaction: lessons learned from the pathogen Mycobacterium tuberculosis. Semin Immunopathol, 2018, 40(6): 577-591. doi:10.1007/s00281-018-0710-0.
pmid: 30306257
|
[48] |
Hlaka L, Ozturk M, Chia JE, et al. IL-4i 1 Regulation of Immune Protection During Mycobacterium tuberculosis Infection. J Infect Dis, 2021, 224(12): 2170-2180. doi:10.1093/infdis/jiab558.
|
[49] |
Ledford H. Moderna COVID vaccine becomes second to get US authorization. Nature, 2020. doi:10.1038/d41586-020-03593-7.
|
[50] |
Lin W, Fan S, Liao K, et al. Engineering zinc oxide hybrid selenium nanoparticles for synergetic anti-tuberculosis treatment by combining Mycobacterium tuberculosis killings and host cell immunological inhibition. Front Cell Infect Microbiol, 2023, 12: 1074533. doi:10.3389/fcimb.2022.1074533.
|